acetylcysteine has been researched along with Alveolitis, Fibrosing in 69 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (2.90) | 18.7374 |
1990's | 13 (18.84) | 18.2507 |
2000's | 20 (28.99) | 29.6817 |
2010's | 29 (42.03) | 24.3611 |
2020's | 5 (7.25) | 2.80 |
Authors | Studies |
---|---|
Avdeev, SN; Izquierdo, JL; Micheletto, C; Pacheco Gallego, MC; Rada Escobar, RA | 1 |
Guan, Y; Li, G; Liu, N; Ma, Z; Wang, R; Yao, S; Zhao, L | 1 |
Li, G; Liu, Y; Niu, D; Qu, Y; Ye, W; Zhang, Q; Zhao, X; Zhao, Z | 1 |
El Kiki, SM; Hasan, HF; Mansour, HH; Omran, MM | 1 |
Li, SQ; Zou, H | 1 |
Chen, JM; Hu, Y; Li, CL; Li, HP; Li, QH; Li, Y; Wang, LS; Weng, D | 1 |
Chen, J; Chen, M; Huang, H; Li, X; Liu, F; Liu, M; Wang, J; Wu, H | 1 |
Cottin, V | 2 |
Jiang, H; Yin, G; Zhang, C; Zhang, H | 1 |
Ancochea, J; Valenzuela, C | 1 |
Bai, YP; Chen, G; Hao, XH; He, YL; Jin, YL; Li, QZ; Liu, N; Yao, SQ; Yuan, JX; Yun, X; Zhang, L; Zhang, ZF | 1 |
Du, ZZ; Li, L; Sun, X; Wang, CZ; Wu, Q; Yu, HZ | 1 |
Chen, C; Guan, X; Ouyang, B; Quinn, DA | 1 |
Álvarez-Sala Walther, R; Gómez Carrera, L | 1 |
Chen, J; Chen, R; Feng, L; Jiang, Z; Li, X; Lou, J; Xia, H; Xiao, Y; Yin, X; Yu, M; Zhang, X; Zhu, L | 1 |
Li, T; Wang, HQ | 1 |
Martinez, F; Noth, I; Raghu, G | 1 |
Albera, C; Behr, J; Crestani, B; Kirchgaessler, K; Wells, A | 1 |
Behr, J; Costabel, U | 1 |
Haraguchi, N; Hizawa, N; Ishii, T; Ishii, Y; Kikuchi, N; Masuko, H; Morishima, Y; Sakamoto, T; Warabi, E; Yageta, Y; Yamadori, T; Yanagawa, T | 1 |
Barron, JT; Grady, EC; Wagner, RH | 1 |
Zhang, CL; Zhang, H | 1 |
Chen, J; Guan, XD; Li, XF; Ouyang, B; Wu, JF | 1 |
Anstrom, KJ; King, TE; Lasky, JA; Martinez, FJ; Raghu, G | 1 |
Ko, JL; Lee, H; Tang, SC; Wang, PH; Wu, CH | 1 |
Auten, RL; Brass, DM; Dunkel, MK; Fattman, CL; Hollingsworth, JW; Latoche, JD; Li, Z; Potts-Kant, E; Reilly, SM; Spencer, JC | 1 |
Abbasi, H; Aran, S; Ghaffari, A; Keshavarz, A; Seifirad, S; Taslimi, S | 1 |
Behr, J | 2 |
Hirano, S; Iikura, M; Izumi, S | 1 |
Hanada, S; Kishi, K; Uruga, H | 1 |
De Capadocia Rosell, J; Jiménez Vizuete, JM; Lozano Serrano, B; Mateo Cerdá, CM | 1 |
Chen, L; Li, J; Li, S; Li, W; Su, X; Yan, G; Yang, X | 1 |
El-Maraghy, SA; Hamdy, MA; Kortam, MA | 1 |
Lota, HK; Wells, AU | 1 |
Arreola, JL; Barrios, R; Cisneros-Lira, J; Gaxiola, M; Kala, SV; Lieberman, MW; Pardo, A; Ramírez, R; Ruiz, V; Selman, M | 1 |
Blesa, S; Bulbena, O; Closa, D; Cortijo, J; Estrela, JM; Martinez-Losa, M; Morcillo, EJ; Prats, N; Serrano-Mollar, A | 1 |
Cerdá, M; Cortijo, J; Llombart-Bosch, A; Martinez-Losa, M; Mata, M; Morcillo, EJ; Ruíz, A; Santangelo, F; Serrano-Mollar, A | 1 |
Flaherty, KR; Lynch, JP; Martinez, FJ; Thannickal, VJ | 1 |
Armutcu, F; Iraz, M; Kotuk, M; Kuku, I; Ozen, S; Ulu, R; Yildirim, Z | 1 |
Hashimoto, K; Imanaka, K; Iwasaki, H; Kuwata, Y; Ohnishi, H; Sakamoto, H; Tada, K; Tomioka, H | 1 |
Behr, J; Buhl, R; Capron, F; Corvasce, G; Costabel, U; De Vuyst, P; Dekhuijzen, R; Demedts, M; Flower, CD; Jansen, HM; Lankhorst, I; Laurent, F; MacNee, W; Montanari, M; Nicholson, AG; Petruzzelli, S; Rodriguez-Becerra, E; Sardina, M; Thomeer, M; van den Bosch, JM; Verbeken, EK; Verschakelen, J; Wallaert, B | 1 |
Hunninghake, GW | 1 |
Hull, JH | 1 |
Bhowmik, A; Rajakulasingam, R; Toma, TP | 1 |
Nathan, SD | 1 |
Wells, AU | 1 |
Eickelberg, O; Günther, A; Markart, P; Seeger, W | 1 |
Collard, HR; King, TE; Walter, N | 1 |
Bennett, L; Crouse, R; Feldstein, D | 1 |
Aburatani, H; Fukayama, M; Goto, A; Ishikawa, S; Kuriyama, T; Li, CP; Murata, K; Niki, T; Ota, S; Ruriko, UM | 1 |
Oehme, FW; Onyeama, HP | 1 |
MacNee, W; Rahman, I | 1 |
Buhl, R; Kampf, S; Magnussen, H; Meyer, A | 1 |
Brien, JF; Leeder, RG; Massey, TE | 1 |
DeRemee, RA | 1 |
Buhl, R; Magnussen, H; Meyer, A | 1 |
Buhl, R; Meyer, A; Vogelmeier, C | 1 |
Behr, J; Degenkolb, B; Krombach, F; Maier, K; Vogelmeier, C | 1 |
Entzian, P | 1 |
Hagiwara, SI; Ishii, Y; Kitamura, S | 1 |
Bioque, G; Cerdá-Nicolás, M; Cortijo, J; Esteras, A; Estrela, JM; Llombart-Bosch, A; Morcillo, EJ; Santangelo, F; Serrano, A | 1 |
Behr, J; Degenkolb, B; Krombach, F; Vogelmeier, C | 1 |
Jeffery, PK; Laurent, GJ; McAnulty, RJ; Sarnstrand, B; Shahzeidi, S | 1 |
Ruffmann, R; Wendel, A | 1 |
Magnussen, H; Meyer, A | 1 |
Nolte, D | 1 |
Giri, SN; Hyde, DM; Schiedt, MJ | 1 |
12 review(s) available for acetylcysteine and Alveolitis, Fibrosing
Article | Year |
---|---|
[Research on the therapeutic effects of drugs on patients with pneumoconiosis in China].
Topics: Acetylcysteine; Benzylisoquinolines; Bronchoalveolar Lavage; China; Forced Expiratory Volume; Humans; Pneumoconiosis; Pulmonary Fibrosis; Quinolines; Research; Respiratory Tract Infections; Treatment Outcome; X-Ray Film | 2016 |
The evolving pharmacotherapy of pulmonary fibrosis.
Topics: Acetylcysteine; Anti-Inflammatory Agents, Non-Steroidal; Humans; Idiopathic Interstitial Pneumonias; Immunosuppressive Agents; Indoles; Lung Diseases, Interstitial; Pulmonary Fibrosis; Pyridones; Randomized Controlled Trials as Topic; Sarcoidosis, Pulmonary; Scleroderma, Systemic; Treatment Outcome | 2013 |
Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapy.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Connective Tissue Growth Factor; Eicosanoids; Endothelin-1; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Interferon-gamma; Molybdenum; Protein Kinase Inhibitors; Proteins; Pulmonary Fibrosis; Pyridones; Recombinant Proteins; Relaxin; Renin-Angiotensin System; Tumor Necrosis Factor-alpha | 2004 |
Therapeutic management of idiopathic pulmonary fibrosis: an evidence-based approach.
Topics: Acetylcysteine; Azathioprine; Benzamides; Bosentan; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Etanercept; Evidence-Based Medicine; Humans; Imatinib Mesylate; Immunoglobulin G; Interferon-gamma; Piperazines; Prednisone; Pulmonary Fibrosis; Pyridones; Pyrimidines; Receptors, Tumor Necrosis Factor; Sulfonamides | 2006 |
[Pulmonary fibrosis--a therapeutic dilemma?].
Topics: Acetylcysteine; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Benzamides; Bosentan; Cyclophosphamide; Drug Therapy, Combination; Etanercept; Free Radical Scavengers; Humans; Imatinib Mesylate; Immunoglobulin G; Immunosuppressive Agents; Interferon-gamma; Lung Transplantation; Piperazines; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyridones; Pyrimidines; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Sulfonamides | 2006 |
Current perspectives on the treatment of idiopathic pulmonary fibrosis.
Topics: Acetylcysteine; Anticoagulants; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Humans; Immunosuppressive Agents; Interferon-gamma; Lung Transplantation; Prednisone; Pulmonary Fibrosis; Pyridones; Quality of Life; Recombinant Proteins | 2006 |
[Idiopathic interstitial pneumonia: treatment].
Topics: Acetylcysteine; Acute Disease; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Azathioprine; Benzamides; Bronchiolitis Obliterans; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colchicine; Cyclophosphamide; Diagnosis, Differential; Disease Progression; Female; Free Radical Scavengers; Humans; Imatinib Mesylate; Immunologic Factors; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pulmonary Fibrosis; Pyrimidines; Randomized Controlled Trials as Topic; Retrospective Studies; Sex Factors | 2006 |
A literature review of paraquat toxicity.
Topics: Acetylcysteine; Animals; Butylated Hydroxytoluene; Clofibrate; Collagen; Diquat; Drug Synergism; Humans; Niacin; Oxygen; Paraquat; Pulmonary Fibrosis; Rats; Superoxide Dismutase; Vitamin E | 1984 |
Oxidants/antioxidants in idiopathic pulmonary fibrosis.
Topics: Acetylcysteine; Adult; Animals; Antioxidants; Bronchoalveolar Lavage Fluid; Cyclophosphamide; Glutathione; Humans; Lung; Male; Middle Aged; Oxidants; Prednisolone; Pulmonary Fibrosis | 1995 |
Oxidant-protease interaction in the lung. Prospects for antioxidant therapy.
Topics: Acetylcysteine; Aerosols; Antioxidants; Glutathione; HIV Infections; Humans; Lung; Lung Diseases; Protease Inhibitors; Pulmonary Fibrosis | 1996 |
[New therapy concepts in fibrosing lung diseases].
Topics: Acetylcysteine; Glutathione; Humans; Prodrugs; Pulmonary Fibrosis | 1996 |
GSH rescue by N-acetylcysteine.
Topics: Acetylcysteine; Acquired Immunodeficiency Syndrome; Glutathione; Humans; Pulmonary Fibrosis; Respiratory Distress Syndrome | 1991 |
6 trial(s) available for acetylcysteine and Alveolitis, Fibrosing
Article | Year |
---|---|
Treatment switching in idiopathic pulmonary fibrosis: from triple therapy to enrollment into a clinical investigational drug trial.
Topics: Acetylcysteine; Azathioprine; Double-Blind Method; Drugs, Investigational; Humans; Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis; Treatment Outcome | 2013 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Azathioprine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Prednisone; Pulmonary Fibrosis; Treatment Outcome; Vital Capacity | 2012 |
A pilot study of aerosolized N-acetylcysteine for idiopathic pulmonary fibrosis.
Topics: Acetylcysteine; Administration, Inhalation; Aged; Antigens; Antigens, Neoplasm; Biomarkers; Expectorants; Female; Follow-Up Studies; Glycoproteins; Health Status; Humans; Male; Middle Aged; Mucin-1; Mucins; Pilot Projects; Pulmonary Fibrosis; Quality of Life; Radiography; Respiratory Function Tests; Treatment Outcome | 2005 |
High-dose acetylcysteine in idiopathic pulmonary fibrosis.
Topics: Acetylcysteine; Aged; Anti-Inflammatory Agents; Antioxidants; Azathioprine; Double-Blind Method; Drug Therapy, Combination; Exercise Tolerance; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Pulmonary Diffusing Capacity; Pulmonary Fibrosis; Vital Capacity | 2005 |
The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis.
Topics: Acetylcysteine; Administration, Oral; Bronchoalveolar Lavage Fluid; Epithelium; Female; Glutathione; Humans; Lung; Male; Middle Aged; Pulmonary Fibrosis | 1994 |
Intracellular glutathione and bronchoalveolar cells in fibrosing alveolitis: effects of N-acetylcysteine.
Topics: Acetylcysteine; Administration, Oral; Adult; Bronchoalveolar Lavage Fluid; Female; Free Radical Scavengers; Glutathione; Humans; Interleukin-8; Male; Middle Aged; Oxidative Stress; Peroxidase; Prospective Studies; Pulmonary Fibrosis | 2002 |
51 other study(ies) available for acetylcysteine and Alveolitis, Fibrosing
Article | Year |
---|---|
N-acetylcysteine as a therapeutic approach to post-COVID-19 pulmonary fibrosis adjunctive treatment.
Topics: Acetylcysteine; Anti-Inflammatory Agents; Antioxidants; COVID-19 Drug Treatment; Glutathione; Humans; Pulmonary Fibrosis; Quality of Life | 2022 |
N-acetylcysteine alleviates pulmonary alveolar proteinosis induced by indium-tin oxide nanoparticles in male rats: involvement of the NF-κB signaling pathway.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Antioxidants; Indium; Lung; Lung Injury; Male; Nanoparticles; NF-kappa B; Pulmonary Alveolar Proteinosis; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Signal Transduction; Tin Compounds; Tumor Necrosis Factor-alpha | 2022 |
S-allylmercapto-N-acetylcysteine ameliorates pulmonary fibrosis in mice via Nrf2 pathway activation and NF-κB, TGF-β1/Smad2/3 pathway suppression.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Bleomycin; Collagen; Mice; NF-E2-Related Factor 2; NF-kappa B; Pulmonary Fibrosis; Transforming Growth Factor beta1 | 2023 |
Modulation of bleomycin-induced oxidative stress and pulmonary fibrosis by N-acetylcysteine in rats via AMPK/SIRT1/NF-κβ.
Topics: Acetylcysteine; AMP-Activated Protein Kinases; Animals; Bleomycin; Lipid Peroxidation; Lung; Male; NF-kappa B; Oxidative Stress; Platelet-Derived Growth Factor; Pulmonary Fibrosis; Rats; Sirtuin 1 | 2020 |
Pulmonary fibrosis in critically ill patients with novel coronavirus pneumonia during the convalescent stage and a proposal for early intervention.
Topics: Acetylcysteine; Convalescence; COVID-19; COVID-19 Drug Treatment; Early Medical Intervention; Glucocorticoids; Humans; Indoles; Pulmonary Fibrosis; Pyridones; SARS-CoV-2 | 2021 |
Effects of particulate matter from straw burning on lung fibrosis in mice.
Topics: Acetylcysteine; Animals; Bleomycin; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Fires; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Particle Size; Particulate Matter; Pulmonary Fibrosis; Random Allocation; Tumor Necrosis Factor-alpha | 2017 |
N-acetylcysteine tiherapeutically protects against pulmonary fibrosis in a mouse model of silicosis.
Topics: Acetylcysteine; Administration, Oral; Animals; Antioxidants; Crystallization; Disease Models, Animal; Female; Gene Expression Regulation; Glutathione Peroxidase; Interleukin-1beta; Interleukin-4; Interleukin-6; Lung; Mice; Mice, Inbred C57BL; NADPH Oxidase 2; Nitric Oxide Synthase Type II; Oxidative Stress; Pulmonary Fibrosis; Reactive Oxygen Species; Silicon Dioxide; Silicosis; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Xanthine Oxidase | 2019 |
Clinical case: Combined pulmonary fibrosis and emphysema with pulmonary hypertension--clinical management.
Topics: Acetylcysteine; Azathioprine; Disease Management; Humans; Hypertension, Pulmonary; Lung; Male; Middle Aged; Oxygen Inhalation Therapy; Phenylpropionates; Prednisolone; Pulmonary Emphysema; Pulmonary Fibrosis; Pyridazines; Radiography; Smoking | 2013 |
High-dose N-acetylcysteine decreases silica-induced lung fibrosis in the rat.
Topics: Acetylcysteine; Administration, Oral; Animals; Antioxidants; Bronchoalveolar Lavage Fluid; C-Reactive Protein; Hydroxyproline; Inflammation; Interleukin-8; Lung; Male; Malondialdehyde; Pulmonary Fibrosis; Rats; Rats, Wistar; Silicon Dioxide; Tumor Necrosis Factor-alpha | 2013 |
N-acetylcysteine alleviated silica-induced lung fibrosis in rats by down-regulation of ROS and mitochondrial apoptosis signaling.
Topics: Acetylcysteine; Animals; Apoptosis; Down-Regulation; Lung; Male; Membrane Potential, Mitochondrial; Mitochondria; Procollagen; Pulmonary Fibrosis; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Silicon Dioxide | 2014 |
[High-fat diet induces pulmonary fibrosis in rats and inhibitory effects of N-acetylcysteine].
Topics: Acetylcysteine; Animals; Diet, High-Fat; Disease Models, Animal; Lung; Male; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1 | 2013 |
N-Acetylcysteine Inhibits Ventilation-Induced Collagen Accumulation in the Rat Lung.
Topics: Acetylcysteine; Analysis of Variance; Animals; Collagen; Injections, Intravenous; Lung; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Respiration, Artificial; Tidal Volume; Time Factors | 2015 |
[Pulmonary fibrosis].
Topics: Acetylcysteine; Azathioprine; Clinical Trials as Topic; Forecasting; Glucocorticoids; Humans; Indoles; Multicenter Studies as Topic; Prognosis; Pulmonary Fibrosis; Pyridones | 2016 |
[Study on the therapeutic effects of tetrandrine combined with N-acetylcysteine on experimental silicosis of rats].
Topics: Acetylcysteine; Animals; Benzylisoquinolines; Disease Models, Animal; Dust; Hydroxyproline; Interleukin-6; Lung; Malondialdehyde; Pulmonary Fibrosis; Quartz; Rats; Rats, Wistar; Silicon Dioxide; Silicosis; Tumor Necrosis Factor-alpha | 2015 |
N-acetylcysteine for idiopathic pulmonary fibrosis: the door is still open.
Topics: Acetylcysteine; Administration, Inhalation; Humans; Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis; Vital Capacity | 2017 |
N-acetylcysteine for idiopathic pulmonary fibrosis: the door is still open-Authors' reply.
Topics: Acetylcysteine; Administration, Inhalation; Humans; Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis; Vital Capacity | 2017 |
[Interstitial lung diseases - historical development, current status, future prospects].
Topics: Acetylcysteine; Antioxidants; History, 19th Century; Humans; Lung Diseases, Interstitial; Pulmonary Fibrosis; Sarcoidosis | 2010 |
Aggravation of bleomycin-induced pulmonary inflammation and fibrosis in mice lacking peroxiredoxin I.
Topics: Acetylcysteine; Animals; Antibiotics, Antineoplastic; Apoptosis; Bleomycin; Bronchoalveolar Lavage; Cells, Cultured; Dinoprost; Free Radical Scavengers; Inflammation; Lung; Macrophage Migration-Inhibitory Factors; Mice; Mice, Transgenic; Oxidative Stress; Peroxiredoxins; Pulmonary Fibrosis | 2011 |
Development of asystole requiring cardiac resuscitation after the administration of regadenoson in a patient with pulmonary fibrosis receiving n-acetylcysteine.
Topics: Acetylcysteine; Adenosine A2 Receptor Antagonists; Drug Interactions; Expectorants; Heart Arrest; Humans; Male; Middle Aged; Pulmonary Fibrosis; Purines; Pyrazoles; Radionuclide Imaging | 2011 |
[Effects of high-dose N-acetylcysteine on the lung tissues of rats exposed to silica].
Topics: Acetylcysteine; Animals; Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug; Dust; Interleukin-8; Lung; Male; Pulmonary Fibrosis; Rats; Rats, Wistar; Silicon Dioxide; Tumor Necrosis Factor-alpha | 2011 |
[N-acetylcysteine (NAC) inhibited pulmonary fibrosis in acute respiratory distress syndrome (ARDS)].
Topics: Acetylcysteine; Cells, Cultured; Collagen; Fibroblasts; Glutathione; Humans; Lipopolysaccharides; Lung; Pulmonary Fibrosis; Respiratory Distress Syndrome | 2011 |
Nickel-induced epithelial-mesenchymal transition by reactive oxygen species generation and E-cadherin promoter hypermethylation.
Topics: Acetylcysteine; Antigens, Differentiation; Azacitidine; Bronchi; Cadherins; Cell Line, Transformed; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Fibronectins; Free Radical Scavengers; Gene Expression Regulation; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Intercellular Junctions; Nickel; Pulmonary Fibrosis; Reactive Oxygen Species; Respiratory Mucosa | 2012 |
Innate immune activation by inhaled lipopolysaccharide, independent of oxidative stress, exacerbates silica-induced pulmonary fibrosis in mice.
Topics: Acetylcysteine; Administration, Inhalation; Animals; Bronchoalveolar Lavage; Cytokines; Drinking Water; Hydroxyproline; Immunity, Innate; Inflammation; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Protein Carbonylation; Pulmonary Fibrosis; Silicon Dioxide | 2012 |
Effect of pirfenidone on pulmonary fibrosis due to paraquat poisoning in rats.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Ascorbic Acid; Disease Models, Animal; Herbicides; Injections, Intraperitoneal; Injections, Intravenous; Life Expectancy; Male; Paraquat; Pulmonary Fibrosis; Pyridones; Rats; Rats, Wistar; Survival Rate; Vitamin E | 2012 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Azathioprine; Female; Humans; Male; Prednisone; Pulmonary Fibrosis | 2012 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Azathioprine; Female; Humans; Male; Prednisone; Pulmonary Fibrosis | 2012 |
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Topics: Acetylcysteine; Azathioprine; Female; Humans; Male; Prednisone; Pulmonary Fibrosis | 2012 |
[Presentation of a case of Paraquat poisoning].
Topics: Acetylcysteine; Acute Kidney Injury; Adult; Ascorbic Acid; Charcoal; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Diuretics; Fatal Outcome; Furosemide; Gastric Lavage; Hemoperfusion; Humans; Immunosuppressive Agents; Male; Paraquat; Poisoning; Pulmonary Fibrosis; Respiration, Artificial; Respiratory Insufficiency; Rhabdomyolysis; Suicide, Attempted; Vitamin E | 2012 |
N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats.
Topics: Acetylcysteine; Actins; Animals; Antibiotics, Antineoplastic; Bleomycin; Collagen; Disease Models, Animal; Down-Regulation; Free Radical Scavengers; Glutathione; Idiopathic Pulmonary Fibrosis; Lung; Male; Protein-Lysine 6-Oxidase; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1 | 2012 |
Modulatory effects of curcumin and green tea extract against experimentally induced pulmonary fibrosis: a comparison with N-acetyl cysteine.
Topics: Acetylcysteine; Animals; Biomarkers; Bronchoalveolar Lavage Fluid; Camellia sinensis; Curcumin; Cyclophosphamide; Dietary Supplements; Disease Models, Animal; Inflammation Mediators; Lipid Peroxidation; Lung; Male; Plant Extracts; Plant Leaves; Protective Agents; Pulmonary Fibrosis; Rats; Rats, Wistar; Tea | 2012 |
Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice.
Topics: Acetylcysteine; Animals; Bleomycin; Bronchoalveolar Lavage Fluid; Collagen; Cysteine; Disease Models, Animal; gamma-Glutamyltransferase; Glutathione; Inflammation; Leukocyte Count; Matrix Metalloproteinase 9; Mice; Mice, Inbred Strains; Neutrophils; Pulmonary Fibrosis; Severity of Illness Index; Time Factors | 2003 |
In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats.
Topics: Acetonitriles; Acetylcysteine; Animals; Antioxidants; Biomarkers; Bleomycin; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Hydroxyproline; Immunohistochemistry; Lung; Macrophages, Alveolar; Male; NF-kappa B; Organ Size; Oxidative Stress; Pneumonia; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Time Factors; Trityl Compounds | 2003 |
Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats.
Topics: Acetylcysteine; Administration, Inhalation; Administration, Oral; Animals; Antibiotics, Antineoplastic; Bleomycin; Free Radical Scavengers; Gene Expression; Hyperplasia; Lung; Male; Models, Animal; Mucin 5AC; Mucins; Oxidative Stress; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley | 2003 |
Attenuation of bleomycin-induced lung fibrosis by oral sulfhydryl containing antioxidants in rats: erdosteine and N-acetylcysteine.
Topics: Acetylcysteine; Animals; Antioxidants; Bleomycin; Disease Models, Animal; Drug Interactions; Male; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds; Thioglycolates; Thiophenes | 2005 |
Antioxidant therapy for idiopathic pulmonary fibrosis.
Topics: Acetylcysteine; Anti-Inflammatory Agents; Antioxidants; Azathioprine; Drug Therapy, Combination; Glutathione; Humans; Lung; Prednisone; Pulmonary Fibrosis | 2005 |
Acetylcysteine in pulmonary fibrosis.
Topics: Acetylcysteine; Bone Marrow; Glutathione; Humans; Methyltransferases; Pulmonary Fibrosis | 2006 |
Acetylcysteine in pulmonary fibrosis.
Topics: Acetylcysteine; Humans; Outcome Assessment, Health Care; Pulmonary Fibrosis; Vital Capacity | 2006 |
Antioxidant therapy in idiopathic pulmonary fibrosis: hope is kindled.
Topics: Acetylcysteine; Antioxidants; Azathioprine; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Humans; Prednisolone; Pulmonary Fibrosis | 2006 |
Clinical use of evidence-based medicine--clinical questions: Acetylcysteine, a new treatment for an old foe?
Topics: Acetylcysteine; Aged; Anti-Inflammatory Agents; Antioxidants; Azathioprine; Drug Therapy, Combination; Evidence-Based Medicine; Exercise Tolerance; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Pulmonary Diffusing Capacity; Pulmonary Fibrosis; Vital Capacity | 2006 |
p63 - Key molecule in the early phase of epithelial abnormality in idiopathic pulmonary fibrosis.
Topics: Acetylcysteine; Biomarkers; Calcium-Binding Proteins; Cell Line, Tumor; Cluster Analysis; DNA-Binding Proteins; Epithelial Cells; Gene Expression Profiling; Humans; Intercellular Signaling Peptides and Proteins; Jagged-1 Protein; Keratin-14; Keratin-6; Membrane Proteins; Metaplasia; Oligonucleotide Array Sequence Analysis; Protein Isoforms; Protein Precursors; Pulmonary Fibrosis; Respiratory Mucosa; RNA, Small Interfering; Serrate-Jagged Proteins; Trans-Activators; Transcription Factors; Transforming Growth Factor beta1; Tumor Suppressor Proteins | 2007 |
Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals.
Topics: Acetylcysteine; Adult; Aged; Bronchoalveolar Lavage Fluid; Case-Control Studies; Epithelium; Female; Glutathione; Humans; Lung; Male; Middle Aged; Pulmonary Fibrosis | 1995 |
Investigation of the role of oxidative stress in amiodarone-induced pulmonary toxicity in the hamster.
Topics: Acetylcysteine; Allyl Compounds; Amiodarone; Animals; Antioxidants; Butylated Hydroxyanisole; Cricetinae; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Lung; Lung Diseases; Male; Mesocricetus; Oxidative Stress; Pulmonary Fibrosis; Sulfides; Superoxide Dismutase | 1994 |
New approaches to the treatment of pulmonary fibrosis.
Topics: Acetylcysteine; Colchicine; Humans; Lung Transplantation; Prednisone; Pulmonary Fibrosis; Terminology as Topic; Tumor Necrosis Factor-alpha | 1994 |
Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression.
Topics: Acetylcysteine; Antioxidants; Bronchoalveolar Lavage Fluid; Female; Glutathione; Glutathione Disulfide; Humans; Immunosuppressive Agents; Lung; Male; Methionine; Middle Aged; Oxidative Stress; Prospective Studies; Pulmonary Fibrosis | 1997 |
[Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression].
Topics: Acetylcysteine; Drug Therapy, Combination; Female; Free Radical Scavengers; Humans; Immunosuppressive Agents; Male; Middle Aged; Pulmonary Fibrosis | 1998 |
Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice.
Topics: Acetylcysteine; Administration, Inhalation; Animals; Bleomycin; Bronchoalveolar Lavage Fluid; Cell Count; Chemokines; Glutathione; Hydroxyproline; Lipid Peroxides; Male; Mice; Mice, Inbred ICR; Pulmonary Fibrosis | 2000 |
Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats.
Topics: Acetylcysteine; Administration, Oral; Animals; Bleomycin; Bronchoalveolar Lavage Fluid; Free Radical Scavengers; Glutathione; Lung; Male; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Taurine | 2001 |
Oral N-acetylcysteine reduces bleomycin-induced collagen deposition in the lungs of mice.
Topics: Acetylcysteine; Animals; Bleomycin; Collagen; Lung; Mice; Mice, Inbred Strains; Microscopy, Electron; Pulmonary Fibrosis | 1991 |
[The effect of oral N-acetylcysteine on glutathione concentration in bronchoalveolar lavage of patients with fibrosing lung diseases].
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Asbestosis; Bronchoalveolar Lavage Fluid; Female; Fibroblasts; Glutathione; Humans; Male; Middle Aged; Pulmonary Fibrosis | 1991 |
[From mucolytic agent to free radical capture: N-acetylcysteine].
Topics: Acetylcysteine; Antioxidants; Expectorants; Free Radicals; Humans; Pulmonary Fibrosis | 1991 |
Effects of repeated administration of N-acetyl-L-cysteine on sulfhydryl levels of different tissues and bleomycin-induced lung fibrosis in hamsters.
Topics: Acetylcysteine; Animals; Bleomycin; Collagen; Cricetinae; Lung; Male; Mesocricetus; Pulmonary Fibrosis; Sulfhydryl Compounds; Time Factors | 1988 |